HF: heart failure BNP: brain natriuretic peptide EF: ejection fraction Further testing With clinical evaluation and initial tests confirming HF, additional tests to determine the etiology and risk stratification by classifying the stage of HF follow. Workup for coronary artery disease (especially for...
Heart failure (HF) and type 2 diabetes are two highly intertwined diseases that exist in a vicious circle; people with type 2 diabetes are approximately two times more likely to develop HF than those without [1,2,3,4]. Furthermore, 30–40% of people with HF suffer from type 2 diabetes...
230: Utility of BNP Level to Predict Outcomes in a Heart Failure Observation Unit PopulationStudy Objectives B-type natriuretic peptide (BNP) levels are obtained in the emergency department (ED) to differentiate patients with suspected diagnosis of heart failure (HF). Current literature recommends a...
Subsequent analysis revealed decreased plasma brain natriuretic peptide (BNP) levels and increased walking distance on the treadmill, suggesting potential beneficial effects on cardiovascular function. While these results are encouraging, this approach may be further optimized by refining the delivery method ...
Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART-2 study. ESC Heart Fail. 2021;8(2):1027–38. https://doi.org/10.1002/ehf2.12765. Article PubMed Google Scholar Ambrosio G, Leiro MGC, Lund LH, Coiro S, Cardona A, Filippatos ...
METHODS: A retrospective chart search was performed on patients readmitted over a 1-year period. RESULTS: 38.5% of readmissions were classified as PR. None of these patients made prior contact with the DMP. Admission levels of BNP, potassium, urea and creatinine were significantly lower in the ...
heart failure with mid-range ejection fraction definition of heart failure improved ejection fraction Abbreviations ACC American College of Cardiology ACEI angiotensin converting enzyme inhibitor AHA American Heart Association ARB angiotensin receptor blocker ARNI Angiotensin receptor-neprilysin inhibitor BNP brain...
Patients with heart failure and preserved ejection fraction (HFpEF) have a high burden of symptoms and functional limitations, and have a poor quality of life. By targeting cardiometabolic abmormalities, sodium glucose cotransporter 2 (SGLT2) inhibito
This study evaluates the effects of non-invasive home telemonitoring methods of managing congestive heart failure (CHF) patients with particular focus on complexity of intervention, patient characteristics, patient severity, and key enabling technologies (KETs) adopted. Our goal was to capture all possi...
Heart failure (HF) is a manifestation of various end-state of heart diseases [1, 2].The prevalence of HF, a serious public health problem, is increasing every year. The mortality rate of HF is high and seriously affects the quality of life of patients [3]. As with many chronic diseases...